According to SNS Insider, The Cell Therapy Human Raw Materials Market was valued at USD 2.9 billion in 2023 and is projected to reach USD 18.1 billion by 2032, growing at an impressive CAGR of 22.6% ...

The presentation will feature the design and objectives of the Phase 1 study, which marks the first clinical application of ...

PL logistics need to invest in new technology and upskilling programs to scale their cell and gene therapy services.

An international group of gene editing leaders has put out a call for a 10-year ban on heritable human genome editing (HHGE), ...

US FDA places clinical hold on Rocket Pharma's gene therapy phase 2 trial of RP-A501 to treat Danon disease: Cranbury, New Jersey Wednesday, May 28, 2025, 14:00 Hrs [IST] Rocket P ...

With gene therapy offering new hope for thalassemia, experts urge Indian govt to invest in early diagnosis, genetic testing, ...

Cell and gene therapies harbor great hopes for biomedicine. They are becoming increasingly important for diseases that are ...

Genetic defects are exceedingly common, which is not surprising considering just how many cells make up our bodies, including our reproductive cells. While most of these defects have no or only ...

The death of a patient in a trial of an experimental gene therapy casts new shadows over a technology once seen as the future ...

Readers respond: Sexual assault survivor funding at risk May. 22, 2025, 6:00 a.m. The current administration has cut this ...

Rui Tostoes, Chief Technology Officer at ImmuneBridge, shares how his team is redefining preclinical development and ...

A team of researchers at Columbia, Harvard and University of Minnesota has developed a gene editing technique they say could ...